FDA Buzz Sends Health and Wellness Stock Surging

Options traders are swarming HIMS in response

Emma Duncan

Managing Editor

Oct 14, 2024 at 11:03 AM

LLY
HIMS

Shares of Hims & Hers Health Inc (NYSE:HIMS) are popping 10% higher to trade at $20.50 this morning, running higher off good news from the Food and Drug Administration (FDA). The FDA announced it will allow compounding pharmacies to create and sell their own version of Eli Lilly's (LLY) weight-loss drug Mounjaro.

In response, HIMS is enjoying a healthy bull gap, pacing toward its highest close since July, and has now broken above the resistant $20 level. The stock sports a 230% year-over-year gain, but still remain a ways off its mid-June peak.

Over in the options pits, traders are moving in, with 18,000 calls across the tape so far today, volume that's three times the average intraday amount. Most popular is the October 20 call, as well as the November 21 and 23 calls.

A short squeeze could help HIMS return to those summer highs. Short interest dropped 11.7% over the past month, yet the 24.76 million shares sold short still accounts for 14% of the stock's total available float.

Follow @Schaeffers

You Don’t Need 25 Alerts -- You Need ONE You Can Trust!

That’s the idea behind Trade of the Week, Schaeffer’s newest trade alert.

Every Monday morning before the opening bell, you’ll receive a single, expertly researched trade recommendation -- built from the same proprietary research we’ve been using for over four decades.

It’s not just a signal.

It’s a plan designed for traders who are tired of jumping from alert to alert without ever finding their edge.

No juggling alerts. No switching directions mid-week. Just one clear, expertly researched trade idea -- delivered before the market even opens.

👉 JOIN RIGHT NOW FOR JUST $1 TO GET THE NEXT TRADE!